These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18154172)

  • 1. [Low blood bilirubin level: possible diagnostic and prognostic importance].
    Shcherbinina MB
    Klin Med (Mosk); 2007; 85(10):10-4. PubMed ID: 18154172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease.
    Alamdari DH; Ghayour-Mobarhan M; Tavallaie S; Parizadeh MR; Moohebati M; Ghafoori F; Kazemi-Bajestani SM; Paletas K; Pegiou T; Koliakos G
    Clin Biochem; 2008 Apr; 41(6):375-80. PubMed ID: 18191639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating lipid hydroperoxides predict cardiovascular events in patients with stable coronary artery disease: the PREVENT study.
    Walter MF; Jacob RF; Bjork RE; Jeffers B; Buch J; Mizuno Y; Mason RP;
    J Am Coll Cardiol; 2008 Mar; 51(12):1196-202. PubMed ID: 18355658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease.
    Vassalle C; Pratali L; Boni C; Mercuri A; Ndreu R
    Clin Biochem; 2008 Oct; 41(14-15):1162-7. PubMed ID: 18692492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease.
    Papa A; Emdin M; Passino C; Michelassi C; Battaglia D; Cocci F
    Clin Chim Acta; 2008 Sep; 395(1-2):27-31. PubMed ID: 18498767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
    Stefanescu A; Braun S; Ndrepepa G; Koppara T; Pavaci H; Mehilli J; Schömig A; Kastrati A
    Am Heart J; 2008 Feb; 155(2):356-60. PubMed ID: 18215608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of brachial-ankle pulse wave velocity in coronary atherosclerosis and peripheral artery diseases in urban Chinese patients.
    Xu Y; Wu Y; Li J; Ma W; Guo X; Luo Y; Hu D
    Hypertens Res; 2008 Jun; 31(6):1079-85. PubMed ID: 18716354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).
    Brodov Y; Behar S; Goldenberg I; Boyko V; Chouraqui P
    Am J Cardiol; 2009 Jul; 104(2):194-8. PubMed ID: 19576345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease.
    Ozcelik F; Erdogan O; Aktoz M; Ekuklu G; Tatli E; Demir M
    Ann Hematol; 2009 Mar; 88(3):249-53. PubMed ID: 18716775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS
    J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilirubin and the risk of common non-hepatic diseases.
    Rigato I; Ostrow JD; Tiribelli C
    Trends Mol Med; 2005 Jun; 11(6):277-83. PubMed ID: 15949769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
    Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
    Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary biliary cirrhosis and coronary atherosclerosis: protective antioxidant effect of bilirubin.
    Dudnik LB; Azyzova OA; Solovyova NP; Savchenkova AP; Pokrovskaya MA
    Bull Exp Biol Med; 2008 Jan; 145(1):18-22. PubMed ID: 19023993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2].
    Knapik-Kordecka M; Piwowar A; Warwas M
    Wiad Lek; 2007; 60(7-8):329-34. PubMed ID: 18175551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of angiographically significant coronary artery disease in patients with isolated secundum atrial septal defect].
    Cay S; Oztürk S; Cağirci G; Yetim M; Büyükterzi Z
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):451-5. PubMed ID: 19155658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
    Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.